Grocery Outlet Holding Corp. announced it will release its third quarter fiscal 2026 financial results after market close on November 10, 2026. The company will hold a conference call at 4:30pm ET to discuss the results, accessible via live webcast. This update is important for investors tracking the company's performance and growth as a value retailer with over 540 stores across multiple states. The webcast replay will be available for about one year for those who cannot attend live.
Grocery Outlet Holding Corp. prepares to release its third quarter fiscal 2026 earnings on November 10, 2026, providing key data for investors. For readers following Consumer Staples stocks, here is Pluang's market snapshot as of Oct 27, 2026 23:51 WIB: out of 63 priced US stocks in the sector, 9 rose and 54 fell. Notable prices include Albertsons Companies Inc (ACI) at USD 13.69 with a 1-day change of -2.07% and 100% sell order activity, Kroger Co (KR) at USD 65.42 with a 1-day change of -2.02% and 87% buy order activity, and JBS N.V. Class A at USD 12.14 with a 1-day change of -1.98%.
The global drone defense system market is projected to grow from $4.72 billion in 2025 to $18.19 billion by 2030, driven by increasing unauthorized drone incidents and demand for advanced detection and countermeasure technologies. Growth is fueled by...
Eli Lilly has outpaced Novo Nordisk in the GLP-1, obesity, and Type 2 Diabetes market, achieving a $1.21 trillion valuation. While Novo Nordisk's share price has fallen back after earlier gains and revenue growth remains flat, its management's strate...
argenx SE announced it will stop its Phase 3 UNITY study of efgartigimod subcutaneous for moderate-to-severe Sjögren's disease after an independent committee found the trial unlikely to meet its primary goal. This decision caused the company's stock ...
Pomerantz LLP is investigating DaVita Inc. for potential securities fraud following a sharp stock price drop triggered by a new U.S. federal strategy targeting the dialysis market. The Department of Health and Human Services announced a plan to incre...
Pomerantz LLP is investigating ClearPoint Neuro and its executives for possible securities fraud following a significant stock price drop. The decline occurred after ClearPoint's partner, uniQure, announced that their Huntington's disease treatment f...
